Stocks and Investing Stocks and Investing
Mon, August 7, 2023

Xiling Chen Maintained (BGNE) at Buy with Increased Target to $300 on, Aug 7th, 2023


Published on 2024-10-28 05:38:09 - WOPRAI, Xiling Chen
  Print publication without navigation


Xiling Chen of JP Morgan, Maintained "BeiGene, Ltd." (BGNE) at Buy with Increased Target from $297 to $300 on, Aug 7th, 2023.

Xiling has made no other calls on BGNE in the last 4 months.



There are 3 other peers that have a rating on BGNE. Out of the 3 peers that are also analyzing BGNE, 2 agree with Xiling's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Rebecca Liang of "Bernstein" Downgraded from Buy to Hold and Decreased Target to $196 on, Friday, June 30th, 2023
  • David Li of "B of A Securities" Maintained at Hold with Increased Target to $263 on, Wednesday, April 12th, 2023


This is the rating of the analyst that currently disagrees with Xiling


  • Yigal Nochomovitz of "Citigroup" Initiated at Strong Buy and Held Target at $275 on, Monday, July 17th, 2023

Contributing Sources